BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15857148)

  • 1. Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
    Ferlin MG; Chiarelotto G; Gasparotto V; Dalla Via L; Pezzi V; Barzon L; Palù G; Castagliuolo I
    J Med Chem; 2005 May; 48(9):3417-27. PubMed ID: 15857148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.
    Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E
    J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein.
    Lee BD; Li Z; French KJ; Zhuang Y; Xia Z; Smith CD
    J Med Chem; 2004 Mar; 47(6):1413-22. PubMed ID: 14998330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA binding ellipticine analogues: synthesis, biological evaluation, and structure-activity relationships.
    Ferlin MG; Marzano C; Gandin V; Dall'Acqua S; Dalla Via L
    ChemMedChem; 2009 Mar; 4(3):363-77. PubMed ID: 19197924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
    Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
    J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of novel thienopyrrolizinones as antitubulin agents.
    Lisowski V; Léonce S; Kraus-Berthier L; Sopková-de Oliveira Santos J; Pierré A; Atassi G; Caignard DH; Renard P; Rault S
    J Med Chem; 2004 Mar; 47(6):1448-64. PubMed ID: 14998333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-substituted 7-phenyl-pyrroloquinolinones show potent cytotoxic activity in human cancer cell lines.
    Gasparotto V; Castagliuolo I; Ferlin MG
    J Med Chem; 2007 Nov; 50(22):5509-13. PubMed ID: 17915851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.
    Tseng CH; Tzeng CC; Yang CL; Lu PJ; Chen HL; Li HY; Chuang YC; Yang CN; Chen YL
    J Med Chem; 2010 Aug; 53(16):6164-79. PubMed ID: 20662543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors.
    Ferlin MG; Carta D; Bortolozzi R; Ghodsi R; Chimento A; Pezzi V; Moro S; Hanke N; Hartmann RW; Basso G; Viola G
    J Med Chem; 2013 Oct; 56(19):7536-51. PubMed ID: 24025069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of 7-phenyl-6,9-dihydro-3H-pyrrolo[3,2-f]quinolin-9-ones: a new class of antimitotic agents devoid of aromatase activity.
    Gasparotto V; Castagliuolo I; Chiarelotto G; Pezzi V; Montanaro D; Brun P; Palù G; Viola G; Ferlin MG
    J Med Chem; 2006 Mar; 49(6):1910-5. PubMed ID: 16539377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel.
    Yamori T; Matsunaga A; Sato S; Yamazaki K; Komi A; Ishizu K; Mita I; Edatsugi H; Matsuba Y; Takezawa K; Nakanishi O; Kohno H; Nakajima Y; Komatsu H; Andoh T; Tsuruo T
    Cancer Res; 1999 Aug; 59(16):4042-9. PubMed ID: 10463605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New water soluble pyrroloquinoline derivatives as new potential anticancer agents.
    Ferlin MG; Marzano C; Dalla Via L; Chilin A; Zagotto G; Guiotto A; Moro S
    Bioorg Med Chem; 2005 Aug; 13(15):4733-9. PubMed ID: 15936202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of polyenylpyrrole derivatives as anticancer agents acting through caspases-dependent apoptosis.
    Fang Z; Liao PC; Yang YL; Yang FL; Chen YL; Lam Y; Hua KF; Wu SH
    J Med Chem; 2010 Nov; 53(22):7967-78. PubMed ID: 20964408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs.
    Romero M; Renard P; Caignard DH; Atassi G; Solans X; Constans P; Bailly C; Pujol MD
    J Med Chem; 2007 Jan; 50(2):294-307. PubMed ID: 17228871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methoxy- and methyl-, methoxy-5,6,11-trimethyl-6H-indolo [2,3-b]quinolinium derivatives as novel cytotoxic agents and DNA topoisomerase II inhibitors.
    Kaczmarek L; Peczyńska-Czoch W; Opolski A; Wietrzyk J; Marcinkowska E; Boratyński J; Osiadacz J
    Anticancer Res; 1998; 18(4C):3133-8. PubMed ID: 9713522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor agents 6. Synthesis, structure-activity relationships, and biological evaluation of spiro[imidazolidine-4,3'-thieno[2,3-g]quinoline]-tetraones and spiro[thieno[2,3-g]quinoline-3,5'-[1,2,4]triazinane]-tetraones with potent antiproliferative activity.
    Bolognese A; Correale G; Manfra M; Esposito A; Novellino E; Lavecchia A
    J Med Chem; 2008 Dec; 51(24):8148-57. PubMed ID: 19053767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor properties of N-[2-(dimethylamino)ethyl]carboxamide derivatives of fused tetracyclic quinolines and quinoxalines: a new class of putative topoisomerase inhibitors.
    Deady LW; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1997 Jun; 40(13):2040-6. PubMed ID: 9207945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins.
    Bailly C; Bal C; Barbier P; Combes S; Finet JP; Hildebrand MP; Peyrot V; Wattez N
    J Med Chem; 2003 Dec; 46(25):5437-44. PubMed ID: 14640552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
    El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
    Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
    Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
    Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.